New
HealthMore in Health →
Study links tumor splicing burden to treatment response in metastatic renal cell carcinoma
Researchers at City of Hope and TGen report a significant correlation between a tumor’s splicing burden and clinical response to treatment in metastatic renal cell carcinoma.
Key Takeaways
- Researchers reported a significant correlation between splicing burden and treatment response.
- The study focuses on metastatic renal cell carcinoma.
DE
DT Editorial AI··via medicalxpress.com